Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Non-interventional, Prospective Cohort Study for Determination of Prevalence and Features of HRRm mCRPC (ADAM)

NCT04712890 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04712890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04712890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Non-interventional, Prospective Cohort Study for Determination of Prevalence and Features of HRRm mCRPC (ADAM)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 23, 2020
Completion date
September 30, 2022
Enrollment
331 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hrrm mcrpc